4.5 Article

Linear predictive coding distinguishes spectral EEG features of Parkinson's disease

Journal

PARKINSONISM & RELATED DISORDERS
Volume 79, Issue -, Pages 79-85

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2020.08.001

Keywords

EEG; Parkinson's disease; Diagnosis; Classifier

Funding

  1. National Institutes of Health [NIH R01NS100849-01A1]

Ask authors/readers for more resources

Objective: We have developed and validated a novel EEG-based signal processing approach to distinguish PD and control patients: Linear-predictive-coding EEG Algorithm for PD (LEAPD). This method efficiently encodes EEG time series into features that can detect PD in a computationally fast manner amenable to real time applications. Methods: We included a total of 41 PD patients and 41 demographically-matched controls from New Mexico and Iowa. Data for all participants from New Mexico (27 PD patients and 27 controls) were used to evaluate in-sample LEAPD performance, with extensive cross-validation. Participants from Iowa (14 PD patients and 14 controls) were used for out-of-sample tests. Our method utilized data from six EEG leads which were as little as 2 min long. Results: For the in-sample dataset, LEAPD differentiated PD patients from controls with 85.3 +/- 0.1% diagnostic accuracy, 93.3 +/- 0.5% area under the receiver operating characteristics curve (AUC), 87.9 +/- 0.9% sensitivity, and 82.7 +/- 1.1% specificity, with multiple cross-validations. After head-to-head comparison with state-of-the-art methods using our dataset, LEAPD showed a 13% increase in accuracy and a 15.5% increase in AUC. When the trained classifier was applied to a distinct out-of-sample dataset, LEAPD showed reliable performance with 85.7% diagnostic accuracy, 85.2% AUC, 85.7% sensitivity, and 85.7% specificity. No statistically significant effect of levodopa-ON and levodopa-OFF sessions were found. Conclusion: We describe LEAPD, an efficient algorithm that is suitable for real time application and captures spectral EEG features using few parameters and reliably differentiates PD patients from demographically-matched controls.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available